Astech Neutraceuticals India Private Limited
About Astech Neutraceuticals India Private Limited
Data last updated:
Astech Neutraceuticals India Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52609DL2019PTC355748. Its GSTIN is 06AASCA7858D1ZA (Haryana).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Reena Sharma and Aruna Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No – 1 G/Floor 20B Krishna Nagar Radha Apartments 2 S.J. Enclave, Delhi, India – 110029.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.65 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹1.51 Lakh (net margin 0.9%) and EBITDA of ₹3.32 Lakh (EBITDA margin 2%). Revenue has grown at a compounded annual rate (CAGR) of 72% over three years.
Company details
Contact details
Astech Neutraceuticals India Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No – 1 G/Floor 20B Krishna Nagar Radha Apartments 2 S.J. Enclave, Delhi, India – 110029
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Astech Neutraceuticals India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Astech Neutraceuticals India is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Astech Neutraceuticals India Private Limited, buy the company report.
Financials of Astech Neutraceuticals India Private Limited
FY 2025 filings availableAstech Neutraceuticals India Private Limited reported revenue of ₹1.65 Cr (up 7% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 72% over three years, including 7% growth in the latest year. EBITDA rose 428% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.32 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.51 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Astech Neutraceuticals India Private Limited, buy the company report.
Board of directors of Astech Neutraceuticals India Private Limited
Astech Neutraceuticals India has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Reena Sharma | Director | 01 Oct 2019 | 7 Years 1 Months | Current |
| Aruna Sharma | Director | 01 Oct 2019 | 7 Years 1 Months | Current |
Peer comparison
Astech Neutraceuticals India Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of chemicals and chemical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| C Tech Nutriscience Private Limited | ₹1.65 Cr (FY 2024) | -23.0% | Rampurwadi, Maharashtra, India | |||
| Bombay Alkalodis Private Limited | ₹1.65 Cr (FY 2024) | 244.0% | Mumbai, Maharashtra, India | |||
| Chetana Labs Private Limited | ₹1.65 Cr (FY 2025) | 338.0% | Nashik, Maharashtra, India | |||
| Resa Agrotech Private Limited | ₹1.65 Cr (FY 2025) | 174.0% | Pune, Maharashtra, India | |||
| Fabricolor Pvt Ltd | ₹1.65 Cr (FY 2024) | -16.0% | Mumbai, Maharashtra, India | |||
| Astech Neutraceuticals India Private Limitedthis company | ₹1.65 Cr (FY 2024) | ₹1.51 Lakh | 0.9% | 7.0% | Delhi, India | |
| Nabad Marketing Private Limited | ₹1.63 Cr (FY 2025) | Kozhikode, Kerala, India | ||||
| Pacific Aesthetic India Private Limited | ₹1.62 Cr (FY 2023) | -61.0% | Mumbai, Maharashtra, India | |||
| Heilig Seals & Liners Private Limited | ₹1.62 Cr (FY 2025) | 159.0% | Ghaziabad, Uttar Pradesh, India | |||
| Saptarang Polymers Private Limited | ₹1.62 Cr (FY 2025) | -12.0% | Wai, Maharashtra, India | |||
| Gram Mooligai Co Limited | ₹1.61 Cr (FY 2025) | 50.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Astech Neutraceuticals India Private Limited, buy the company report.
Auditor
Astech Neutraceuticals India Private Limited is audited by GOVIND SINGH & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GOVIND SINGH & CO | FY 2022 | 030920N |
Shareholding
The shareholding of Astech Neutraceuticals India Private Limited is on record for 3 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Astech Neutraceuticals India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Astech Neutraceuticals India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Astech Neutraceuticals India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Astech Neutraceuticals India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AASCA7858D1ZA | Haryana | Active | 08 Nov 2019 |
To see the full GST registrations and return filing status of Astech Neutraceuticals India Private Limited, buy the company report.
Recent activity
Astech Neutraceuticals India Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Aruna Sharma was appointed as Director on 01 Oct 2019.
Frequently asked questions
Astech Neutraceuticals India is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 October 2019 (7+ years old) and is registered under CIN U52609DL2019PTC355748.
Astech Neutraceuticals India has 2 current directors:
- Reena Sharma - Director
- Aruna Sharma - Director
The latest financial statements of Astech Neutraceuticals India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Astech Neutraceuticals India is 06AASCA7858D1ZA, registered in Haryana.
The CIN (Corporate Identification Number) of Astech Neutraceuticals India is U52609DL2019PTC355748. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Astech Neutraceuticals India was incorporated on 01 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Astech Neutraceuticals India by revenue are C Tech Nutriscience Private Limited, Bombay Alkalodis Private Limited, Chetana Labs Private Limited, Resa Agrotech Private Limited, Fabricolor Pvt Ltd and 5 more, all in the same principal business activity (manufacture of chemicals and chemical products).
Aruna Sharma was appointed as Director on 01 Oct 2019. Reena Sharma was appointed as Director on 01 Oct 2019.
The registered office of Astech Neutraceuticals India is at Flat No – 1 GFloor 20B Krishna Nagar Radha Apartments 2 S.J. Enclave, Delhi, India – 110029.
Astech Neutraceuticals India operates in the pharma industry, in the drug formulation and development segment.
Astech Neutraceuticals India can be reached at its registered office: Flat No – 1 GFloor 20B Krishna Nagar Radha Apartments 2 S.J. Enclave, Delhi, India – 110029.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
